Trade NCEL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
NewcelX Ltd. (NCEL) is trading at US$3.32, down 2.92% today as of Aug 28, 12:21 EDT. The company has a market capitalisation of US$18.7M. Over the past 52 weeks, NCEL has traded between US$1.83 and US$24.60. On Syfe you can trade NCEL with $0 commission and add it to your watchlist.
| Previous close | US$3.42 |
|---|---|
| Market cap | US$18.7M |
| 52-week range | US$1.83 – US$24.60 |
| Volume | 19.9K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NewcelX Ltd.
NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland.
Year: 2021
NewcelX Obtains Patent in Brazil for Potential Type 1 Diabetes Treatment
Jul 15, 1:20 PM · MT Newswires
NewcelX Ltd. (NCEL) stock is trading at US$3.32, -2.92% from the previous close of US$3.42.
The market cap for NewcelX Ltd. (NCEL) stock is approximately US$18.7M.
The 52-week high for NewcelX Ltd. (NCEL) stock is US$24.60.
The 52-week low for NewcelX Ltd. (NCEL) stock is US$1.83.
NewcelX Ltd. (NCEL) does not currently pay a dividend.
Stay on top of NCEL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
